Clinical Profile of Relaxin, a Possible New Drug for Human Use

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|4|3|238-249

ISSN： 1574-8863

Source： Current Drug Safety, Vol.4, Iss.3, 2009-09, pp. : 238-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist

By  

EPILEPSIA, Vol. 56, Iss. 1, 2015-01 ,pp. : 12-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relaxin as a Cardiovascular Drug: A Promise Kept

By  

Current Drug Safety, Vol. 6, Iss. 5, 2011-11 ,pp. : 324-328

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical drug interaction profile of idelalisib in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 8, 2015-08 ,pp. : 909-919

John Wiley & Sons Inc

Access to resources Recommend Favorite

A possible explanation for relaxin and oxytocin receptors in the uterosacral ligaments

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 4, 2015-04 ,pp. : 440-440

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1097-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite